Matthew Winkler

Insider Reports History

Entity
Individual
Location
C/O Mirna Therapeutics, Inc., 2150 Woodward St., Suite 100, Austin, TX
Signature
/s/ Matthew Winkler, by Brian McKelligon, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Winkler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akoya Biosciences, Inc. Director Common Stock 985K $4.41M $4.48 Jun 12, 2023 Direct
Akoya Biosciences, Inc. Director Stock Option (Right to Buy) 50K Jun 4, 2024 Direct

Insider Reports Filed by Matthew Winkler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKYA Akoya Biosciences, Inc. Jun 4, 2024 1 $0 4 Jun 5, 2024 Director
AKYA Akoya Biosciences, Inc. Jun 12, 2023 1 $1.02M 4 Jun 12, 2023 Director
AKYA Akoya Biosciences, Inc. Jun 1, 2023 1 $0 4 Jun 5, 2023 Director
AKYA Akoya Biosciences, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
AKYA Akoya Biosciences, Inc. May 21, 2021 1 $0 4 May 25, 2021 Director